MyoPax Raises Pre-Seed Funding

Berlin-based developer MyoPax raised a pre-seed funding round from B# Plus, a variant of the IBB Ventures fund. The company intends to use the undisclosed amount to advance pharmaceutical manufacturing and establish prerequisites for its first clinical trials.